pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Fierce Biotech·20h ago·1 min read
save

Oura and UC San Diego Health launch trial linking smart ring data to obesity treatment outcomes

Oct 28, 2026·read at Fierce Biotech ↗Positive

Oura and UC San Diego Health have partnered on a multi-year clinical trial called SMART-BMI to explore how continuous data from the Oura Ring may reflect patient response to obesity therapies.

The study will enroll patients receiving GLP-1 drugs or undergoing bariatric surgery and will collect ring metrics such as sleep patterns, heart rate, and activity levels between clinic visits.

Researchers will compare these wearable signals with clinical outcomes including weight loss, HbA1c changes and treatment persistence to see if the data can serve as early indicators of success.

The trial is registered on ClinicalTrials.gov (NCT07736729) and aims to demonstrate how wearable technology can support precision medicine in obesity management.

source

This writeup was produced by pharmadog from original reporting by Fierce Biotech.

Original headline: “Oura, UC San Diego Health collaborate to study GLP-1 outcomes using continuous smart ring data”

read at Fierce Biotech ↗
809 words · retrieved 35m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

drugs
Obesity9
topics
Obesity11Cardiology5GLP-1 receptor5Endocrinology & Metabolism2Hematology2Heart FailureMajor DepressionNephrologyPsychiatry & CNS

related stories

  • Jul 18Opinion: STAT readers on the value of primary care, obesity as a disease, and moreSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Aug 5Novo CEO accepts ‘couple of setbacks’ in R&D as CagriSema posts more mixed dataFierce Biotech
  • Jul 28After PCOS became PMOS, there’s hope for new awareness among Black and Latina womenSTAT
  • Jul 18Opinion: Beware the unintended consequences of testosterone screening for military servicemembersSTAT